Orlistat , >97.0%(HPLC) , 96829-58-2
Synonym(s):
(−)-Tetrahydrolipstatin;N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;Orlistat;Ro-18-0647
CAS NO.:96829-58-2
Empirical Formula: C29H53NO5
Molecular Weight: 495.73
MDL number: MFCD05662360
EINECS: 639-755-1
Pack Size | Price | Stock | Quantity |
100MG | RMB31.20 | In Stock |
|
250MG | RMB39.20 | In Stock |
|
1G | RMB56.80 | In Stock |
|
5G | RMB100.00 | In Stock |
|
25G | RMB476.00 | In Stock |
|
100G | RMB1268.00 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | <50 °C |
alpha | D20 -32.0° (c = 1 in chloroform) |
Boiling point: | 615.9±30.0 °C(Predicted) |
Density | 0.976±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: 19 mg/mL |
form | solid |
pka | 14.59±0.23(Predicted) |
color | white |
Merck | 14,6869 |
Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 week. |
InChIKey | AHLBNYSZXLDEJQ-FWEHEUNISA-N |
SMILES | C(O[C@H](C[C@H]1[C@H](CCCCCC)C(=O)O1)CCCCCCCCCCC)(=O)[C@H](CC(C)C)NC=O |
Description and Uses
Orlistat is a digestive lipase inhibitor. It inhibits diacylglycerol lipase α (DAGLα), DAGLβ, α/β-hydrolase domain-containing protein 12 (ABHD12), ABHD16A, and platelet-activating factor acetylhydrolase (PAF-AH; IC50s = 0.06, 0.1, 0.08, 0.03, and 0.05 μM, respectively), as well as pancreatic lipase and hormone-sensitive lipase (IC50s = 0.65 and 2.1 μg/ml, respectively) but does not inhibit fatty acid amide hydrolase (FAAH) or KIAA1363 (IC50s = >100 μM for both). Orlistat decreases ionomycin-induced production of the endocannabinoid 2-arachidonoyl glycerol (2-AG) in N18TG2 murine neuroblastoma cells when used at a concentration of 1 μM. It also inhibits fatty acid synthase (FASN; Kiapp = ~0.1 μM for the human enzyme) and the proliferation of PC3 prostate cancer cells in a concentration-dependent manner. Orlistat (10 mg/kg) decreases serum cholesterol levels and total body weight in a mouse model of obesity induced by a high-fat diet. Formulations containing orlistat have been used in the treatment of adult obesity.
Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.